Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine

Journal of Infection(2022)

引用 7|浏览8
暂无评分
摘要
•SARS-CoV-2 infection after the first BNT162b2 dose does not boost antibody response.•A postponed second dose induced antibody titres similar to those in naïve vaccinees.•We advise a second vaccine dose for individuals infected early after the first dose.
更多
查看译文
关键词
BNT162b2 vaccine,Neutralizing antibody,RBD-binding IgG antibody,SARS-CoV-2 infection,Antibody response,mRNA vaccine,Adverse events,Delayed second vaccine dose
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要